Xoma | XOMA - Loan Capital


Xoma reported $94.38M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Agenus USD 169.66M 146.06M Dec/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Ardelyx USD 203.52M 683K Mar/2026
aTyr Pharma USD 1.72M 10.79M Mar/2026
BioMarin Pharmaceutical USD 1.43B 833.11M Mar/2026
Curis USD 29.43M 10.69M Jun/2024
Eli Lilly USD 39.37B 1.5B Mar/2026
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Incyte USD 29.41M 785K Mar/2026
MacroGenics USD 68.71M 1.29M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Prothena USD 0 0 Dec/2024
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Xoma USD 94.38M 7.82M Sep/2025